Global health concern intensifies as the latest Salmonella outbreak in the United States exposes the growing risks linked to foodborne infections
Drug research in India is undergoing a major shift as the government accelerates support for non-animal testing methods
Ebola outbreak conditions worsen in Congo as confirmed infections cross 4,000, marked as one of the most severe health emergencies
Pharma regulation reform, cancer care access, and drug safety drive the latest developments in the pharmaceutical sector, as policymakers and companies have accelerated structural changes and healthcare outreach
The Semaglutide patent stands at the center of a major Novo Nordisk legal case as the company strengthens pharma patent enforcement across Europe
Pharma companies in India face a stricter test as the Centre amends the Drugs Rules to debar companies that submit fake or fabricated data during drug approval applications
Aurobindo Pharma sets its sights on a USD 200 million revenue target from its TheraNym biologics venture by 2032
The Chandipura virus outbreak has prompted the Central government to deploy a National Joint Outbreak Response Team (NJORT) to Gujarat and Rajasthan, where cases have increased in recent weeks.
Biocon delivered a strong start to FY27 with a sharp rise in earnings. The company's Q1 profit jumped four times year-on-year, supported by steady biosimilars demand. Revenue also increased, reflecting healthy growth across its key business segments.
The latest developments highlight drug approvals, pharma investments, and healthcare innovation shaping the global and Indian pharmaceutical landscape
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")